Literature DB >> 31931841

Rare diseases in Chile: challenges and recommendations in universal health coverage context.

Gonzalo Encina1, Carla Castillo-Laborde2, Juan A Lecaros3, Karen Dubois-Camacho4,5, Juan F Calderón1, Ximena Aguilera2, Andrés D Klein1, Gabriela M Repetto6.   

Abstract

Rare diseases (RDs) are a large number of diverse conditions with low individual prevalence, but collectively may affect up to 3.5-5.9% of the population. They have psychosocial and economic impact on patients and societies, and are a significant problem for healthcare systems, especially for countries with limited resources. In Chile, financial protection exists for 20 known RDs through different programs that cover diagnosis and treatments. Although beneficial for a number of conditions, most RD patients are left without a proper legal structure that guarantees a financial coverage, and in a vulnerable situation. In this review, we present and analyze the main challenges of the Chilean healthcare system and legislation on RDs, and other ambits of the RD ecosystem, including patient advocacy groups and research. Finally, we propose a set of policy recommendations that includes creating a patient registry, eliciting social preferences on health and financial coverage, improving access to clinical genetic services and therapies, promoting research on RDs and establishing a Latin-American cooperation network, all aimed at promoting equitable quality healthcare access for people living with RDs.

Entities:  

Keywords:  Chile; Health policy; Rare diseases; Universal health coverage

Year:  2019        PMID: 31931841     DOI: 10.1186/s13023-019-1261-8

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  5 in total

1.  Ethical Questions Linked to Rare Diseases and Orphan Drugs - A Systematic Review.

Authors:  Jaroslav Kacetl; Petra Marešová; Raihan Maskuriy; Ali Selamat
Journal:  Risk Manag Healthc Policy       Date:  2020-10-13

Review 2.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123

3.  Financing of Rare Diseases and Orphan Drugs in A Sanctioned Country: A Qualitative Study.

Authors:  Seyran Naghdi; Mohammadreza Maleki; Sudabeh Vatankhah
Journal:  Med J Islam Repub Iran       Date:  2022-05-11

4.  Characteristics and factors associated with mortality due to rare diseases in Chile, 2002-2017

Authors:  Jahir Andrés Ávila; Julio César Martínez
Journal:  Biomedica       Date:  2022-09-02       Impact factor: 1.173

5.  Ophthalmic genetics in South America.

Authors:  Malena Daich Varela; Rene Moya; Patricio G Schlottmann; Robert B Hufnagel; Claudia Arberas; Federico M Fernández; M Eugenia Inga; Juliana Lores; Harry Pachajoa; Carlos E Prada; Juliana M Ferraz Sallum
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-08-28       Impact factor: 3.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.